United States of America

January 19, 2022 3M Earplug Trial Update:  The first 3M earplug lawsuit trial of 2022 started last  Monday for two soldier plaintiffs.

Day 6, Tuesday January 18th, saw the expert testimony of Dr. Marc Bennett.  This Vanderbilt doctor has testified before in this litigation.  He spoke to the jury about the hearing injuries suffered.

Monday was a day off from MLK holiday.  The trial resumed on Tuesday.  Friday morning (January 14, 2022) was Day 5.  This trial day mostly involved the testimony of Richard McKinley, a key expert for soldiers in the 3M earplug lawsuits on why the earplugs were defective.

Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas.

Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis.  These NEC formula lawsuits make a lot of allegations.  But at the core of it, are saying – The makers of these formulas knew of the risk of NEC and did nothing to warn families and give them a choice.

If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to bring a product liability lawsuit against the formula company and receive financial compensation for your loss.

This post speculates about Zantac lawsuit settlement amounts.  Yes, it is impossible to know what the average compensation payout might be in the Zantac litigation at this stage.

But projecting settlement amounts is what stock analysts and shareholders for Sanofi-Aventis, Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are already doing and baking those costs into the stock price.  Plaintiffs’ Zantac lawyers can do this as well.

So this post will look at the settlement amounts a Zantac lawsuit might fetch based on comparisons to other mass tort settlements involving cancer.

In June of last year, millions of Philips CPAP and BiPAP sleeping machines were recalled after the company acknowledged that sound abatement foam in the devices was breaking down and causing users to inhale toxic chemicals.

The sweeping recall immediately prompted a wave of CPAP lawsuits. The early plaintiffs in these cases claimed that the recalled devices caused a variety of different health problems including asthma, throat tumors, and general respiratory irritation.

CPAP and Liver Cancer, Kidney Cancer, and Non-Hodgkin’s Lymphoma

People who have developed Parkinson’s from Paraquat want to better understand the range of settlement amounts they can expect in their Paraquat lawsuit.

It is early in the Paraquat litigation so settlement compensation payouts are speculative.  But we can look at other similar injuries to try to get a settlement range if plaintiffs’ lawyers are successful, as expected, in this litigation.  The expected Paraquat settlement amounts will fluctuate as the litigation progress. So our lawyers will continue to update this page.  The last update was on December 18, 2021.

January 2022 Paraquat Update

The CPAP recall lawsuits against Philips have spawned a new group of related satellite lawsuits against SoClean, Inc. SoClean is a company that makes a product that is specifically used to sanitize the recalled CPAP devices.

So far around a dozen lawsuits have been filed against SoClean alleging that that company falsely marketed that their product was “safe” and “healthy” to use for sanitizing CPAP machines and other breathing devices.

According to the lawsuits, SoClean’s product was not safe because it omits harmful levels of ozone gas which exceeded the maximum safe limits set by the FDA.

Right now, there are thousands of lawsuits pending in courts across the country related to defective hernia mesh implants. The plaintiffs in these lawsuits are individuals who had a defective hernia mesh implanted during surgery causing them to suffer serious post-surgical complications and injuries.

The hernia mesh lawsuits involve multiple hernia mesh products made by 3 medical device companies who are now defendants in the litigation: Ethicon (a Johnson & Johnson subsidiary), C.R. Bard (now part of Beckton Dickinson), and Atrium Medical Corp. The alleged defects and the product liability claims being asserted against all these defendants are similar enough to talk about them collectively.

New Hernia Mesh Trial Begins Today Soon

Surgimesh is another type of hernia mesh implant made from polypropylene plastic that is similar in design to the hernia mesh devices that have generated thousands of product liability lawsuits in recent years (e.g., Ethicon Physiomesh, Atrium C-Qur, etc.).

A recently filed product liability lawsuit in New Mexico alleges that the Surgimesh has the same dangerous design flaws as the other polypropylene hernia mesh implants. This new Surgimesh lawsuit could potentially be the first of many and open a new front in the hernia mesh mass tort ligation.

About Surgimesh

Medical device company C.R. Bard Inc. is currently defending 15,000 hernia mesh lawsuits alleging that its mesh devices were defective and resulted in injuries and complications for thousands of hernia surgery patients.

This post will provide a historical overview of the hernia mesh lawsuits against C.R. Bard and look at the current status of the Bard hernia mesh class-action MDL as of January 10, 2022.

January 10, 2022 Mesh Lawsuit Update

A growing number of product liability lawsuits are now being filed alleging that the popular baby formula, Similac, caused premature infants to develop a serious gastrointestinal infection called necrotizing enterocolitis (NEC).

Our national product liability and mass tort firm is seeking potential Similac lawsuits against the formula manufacturer, Abbott Laboratories Inc., for failure to warn about the risks of NEC associated with Similac. If you bring a successful baby formula NEC lawsuit you could receive significant financial compensation.  Our attorneys offer a free online consultation.

This page was updated with a new video on January 5, 2022.

Contact Information